Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | HBB | P68871 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8580238 | 1.00 | TP53 (0.54) | TP53HBBSMN1; SMN2ALDH1A1DHFR | |
| SCHEMBL21991221 | 1.00 | TP53 (0.54) | TP53HBBSMN1; SMN2ALDH1A1DHFR | |
| SCHEMBL24855261 | 0.96 | TP53 (0.50) | TP53HBBSMN1; SMN2ALDH1A1DHFR | |
| SCHEMBL17153972 | 0.96 | TP53 (0.50) | TP53HBBSMN1; SMN2ALDH1A1DHFR | |
| SCHEMBL8577891 | 0.93 | TP53 (0.52) | TP53HBBSMN1; SMN2ALDH1A1DHFR | |
| SCHEMBL12047488 | 0.92 | TP53 (0.47) | TP53HBBSMN1; SMN2ALDH1A1 | |
| SCHEMBL17153973 | 0.92 | TP53 (0.47) | TP53HBBSMN1; SMN2ALDH1A1 | |
| SCHEMBL20495995 | 0.91 | TP53 (0.50) | TP53HBBSMN1; SMN2ALDH1A1DHFR | |
| SCHEMBL20495997 | 0.91 | TP53 (0.50) | TP53HBBSMN1; SMN2ALDH1A1DHFR | |
| SCHEMBL10329459 | 0.91 | TP53 (0.50) | TP53HBBSMN1; SMN2ALDH1A1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2530524-B1 | POSITIVE-TYPE RESIST COMPOSITION AND METHOD FOR PRODUCING MICROLENS | NISSAN CHEMICAL CORP (JP) | 2019-05-29 | — | — | EP | disclosed |